Поиск | Bundas24

Aryan Mhatre добавлена новая статья Другое
2025-06-09 06:47:08 -

Amyloidosis Treatment Market Growth Drivers: Share, Value, Size, and Insights
"Executive Summary Amyloidosis Treatment Market Market : The Global Amyloidosis Treatment Market size was valued at USD 5.15 Billion in 2024 and is expected to reach USD 9.60 Billion by 2032, at a CAGR of 8.10 % during the forecast period Value An international Amyloidosis Treatment Market Market research report is an absolute overview of the...

0 Комментарии 0 Поделились 16 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Ankit Chand добавлена новая статья Health
2025-05-13 09:39:43 -

ATTR Amyloidosis Treatment Market is driven by emerging gene therapies
The ATTR Amyloidosis Treatment Market involves pharmaceutical and biotech products designed to treat transthyretin amyloidosis, a rare disorder caused by misfolded transthyretin proteins that deposit as amyloid fibrils in multiple organs. Key therapies include TTR stabilizers, gene-silencing oligonucleotides, and monoclonal antibodies, each offering distinct advantages like improved patient...

0 Комментарии 0 Поделились 172 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Khushbu Coherent добавлена новая статья Health
2025-05-09 07:49:28 -

ATTR Amyloidosis Treatment Market is driven by Innovation
The ATTR Amyloidosis Treatment Market encompasses therapies focused on transthyretin stabilization and gene-silencing approaches to manage cardiomyopathy and polyneuropathy arising from amyloid fibril deposition. Market products include TTR stabilizers such as tafamidis and diflunisal, RNA interference (RNAi) drugs like patisiran, and antisense oligonucleotides exemplified by inotersen. These...

0 Комментарии 0 Поделились 276 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Khushbu Coherent добавлена новая статья Health
2025-06-04 10:38:25 -

ATTR Amyloidosis Treatment Market is driven by rising market demand
The ATTR Amyloidosis Treatment Market encompasses therapies designed to address transthyretin (ATTR) amyloidosis, a progressive disorder characterized by abnormal protein deposits in organs and tissues. Core products include RNA interference (RNAi) therapies, monoclonal antibodies, and small-molecule stabilizers that prevent transthyretin misfolding. Advantages of these treatments lie in...

0 Комментарии 0 Поделились 88 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!